6533b881fe1ef96bd12d81c7

RESEARCH PRODUCT

One-Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus

Adis Journals On Behalf OfStefano RadelliniEnrica VigneriValentina GuarnottaFelicia PantoCarla Giordano

subject

description

Article full text The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.

https://dx.doi.org/10.6084/m9.figshare.14316128